Home MiMedx

MiMedx

In operation
Post-IPO Round
Biological Agent Developer
Basic
Enterprise Profile

Basic Information

MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts and provides patented protection for various fields of medicine. It uses its proprietary PURION process to process human placental tissue, producing allografts.
MiMedx Group, Inc.
Georgia,United States of America
more than 500 people
February 28, 2008
careers@mimedx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production Wholesale of Western Medicines
Technology
Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs Biological Products